In Q1 FY26, ace investor, Mukul Agrawal, has placed his bet on the shares of Yatharth Hospital & Trauma Care Services. He has bought 1.14% shares of Yatharth Hospitals of the total trading equity shares, as per the latest BSE data. This translates to 11,00,000 shares valued at Rs 66.78 crore as per the closing price of July 16. The July 16 closing price was Rs 607.05 per share.
This is the first time the seasoned investor has bought equity shares in the hospital sector. Before that, he had been an investor in the pharma and healthcare space with Jagsonpal Pharma and Zota Healthcare.
Other key stocks in Mukul Agrawal’s portfolio
Apart from Yatharth Hospital, Mukul Agrawal has bought shares of Jammu & Kashmir Bank for Rs 160 crore in Q1FY26. He has bought 1.4 crore shares of the lender, which is 1.3% of the total equity shares.
Plus, he invested in the shares of Monolithisch, buying a 2.3% stake in it. He bought 5 lakh shares of the company for a value of Rs 21.5 crore in Q1 FY26.
As of July 17 2025, Mukul Agrawal’s portfolio net worth rose by 3.9% to Rs 6,899.64 crore in the first quarter of the financial year 2025-26 from Rs 6,641.4 crore in Q4 FY25, according to the data on Trendlyne.
Yatharth Hospital FY25 performance
The multi-speciality hospital chain operator reported a net profit of Rs 130.6 crore for the whole financial year 2024-25, which was 14% higher year-on-year (YoY) from Rs 114.5 crore posted in the same period a year ago.
The revenue rose 31% to Rs 880.50 crore in FY25, as against Rs 670.50 crore in the financial year 2023-24. On the operating front, EBITDA grew 22% YoY to Rs 220.2 crore. However, the margin dropped by 182 basis points to 25%.
Yatharth Hospital’s stock performance
The stock price of Yatharth Hospital has fallen 1.4% in the last five trading sessions. However, the share price has given a return of 18% in the past one month and 39% in the past six months. Yatharth Hospital’s share price stood at similar levels to those of the last six months.